Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNeuropharmacology

CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor

Lothar Lindemann, Georg Jaeschke, Aubin Michalon, Eric Vieira, Michael Honer, Will Spooren, Richard Porter, Thomas Hartung, Sabine Kolczewski, Bernd Büttelmann, Christophe Flament, Catherine Diener, Christophe Fischer, Silvia Gatti, Eric P. Prinssen, Neil Parrott, Gerhard Hoffmann and Joseph G. Wettstein
Journal of Pharmacology and Experimental Therapeutics November 2011, 339 (2) 474-486; DOI: https://doi.org/10.1124/jpet.111.185660
Lothar Lindemann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georg Jaeschke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aubin Michalon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Vieira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Honer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Will Spooren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Porter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Hartung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Kolczewski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernd Büttelmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Flament
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Diener
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Fischer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Gatti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric P. Prinssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Parrott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Hoffmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph G. Wettstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 339 no. 2 474-486
DOI 
https://doi.org/10.1124/jpet.111.185660
PubMed 
21849627

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received July 4, 2011
  • Accepted August 15, 2011
  • Published online October 19, 2011.

Article Versions

  • Earlier version (August 17, 2011 - 11:43).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Lothar Lindemann,
  2. Georg Jaeschke,
  3. Aubin Michalon,
  4. Eric Vieira,
  5. Michael Honer,
  6. Will Spooren,
  7. Richard Porter,
  8. Thomas Hartung,
  9. Sabine Kolczewski,
  10. Bernd Büttelmann,
  11. Christophe Flament,
  12. Catherine Diener,
  13. Christophe Fischer,
  14. Silvia Gatti,
  15. Eric P. Prinssen,
  16. Neil Parrott,
  17. Gerhard Hoffmann and
  18. Joseph G. Wettstein
  1. Pharmaceuticals Division, Discovery Neuroscience (L.L., A.M., M.H., W.S., R.P., C.D., C.Fi., S.G., E.P.P., J.G.W.), Discovery Chemistry (G.J., E.V., T.H., S.K., B.B.), Nonclinical Safety (C.Fl., N.P., G.H.), and Academic Alliances (R.P.), F. Hoffmann-La Roche Ltd., Basel, Switzerland
  1. Address correspondence to:
    Dr. Lothar Lindemann, F. Hoffmann-La Roche Ltd. Pharmaceuticals Division, Discovery Neuroscience, Grenzacherstrasse 124, 4070 Basel, Switzerland. E-mail: lothar.lindemann{at}roche.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2011 to May 2022

AbstractFullPdf
Aug 20112140141
Sep 2011850120
Oct 201129322128
Nov 20112522060
Dec 2011902735
Jan 2012882857
Feb 2012692748
Mar 2012822150
Apr 201215880125
May 2012933962
Jun 2012851145
Jul 2012491133
Aug 2012481636
Sep 2012572339
Oct 2012421850
Nov 2012464852
Dec 2012523547
Jan 2013593751
Feb 2013415654
Mar 2013385564
Apr 2013353033
May 2013294751
Jun 2013403738
Jul 2013275250
Aug 2013152841
Sep 2013483338
Oct 2013313148
Nov 2013362940
Dec 2013182526
Jan 2014154133
Feb 2014192726
Mar 2014243331
Apr 2014284036
May 2014266037
Jun 2014243328
Jul 2014353318
Aug 2014192514
Sep 2014262718
Oct 2014252818
Nov 2014162221
Dec 2014131919
Jan 2015252114
Feb 2015302221
Mar 2015403033
Apr 2015192128
May 2015163722
Jun 2015222426
Jul 2015173733
Aug 2015142619
Sep 2015203121
Oct 2015143230
Nov 2015153126
Dec 2015401519
Jan 2016192927
Feb 2016161710
Mar 2016162132
Apr 2016191519
May 2016122833
Jun 2016194722
Jul 2016342430
Aug 2016325742
Sep 2016293029
Oct 2016167119
Nov 2016115415
Dec 201673913
Jan 201733512
Feb 201765111
Mar 2017105822
Apr 2017114616
May 2017103321
Jun 2017104123
Jul 201731257
Aug 2017164715
Sep 2017104426
Oct 20178449
Nov 2017104316
Dec 2017145711
Jan 2018165314
Feb 2018135022
Mar 2018154424
Apr 2018117123
May 2018114222
Jun 201894414
Jul 201874013
Aug 20187278
Sep 201834421
Oct 201872532
Nov 201885113
Dec 2018561912
Jan 201945416
Feb 201947618
Mar 2019711425
Apr 201934711
May 201937315
Jun 20193238
Jul 201945510
Aug 20198569
Sep 20194159
Oct 201940812
Nov 20194658
Dec 20195547
Jan 20204366
Feb 2020301411
Mar 2020341613
Apr 202022124
May 20204053
Jun 20203222
Jul 20201603
Aug 20202245
Sep 202072119
Oct 2020501012
Nov 2020511013
Dec 202055205
Jan 2021291712
Feb 2021982445
Mar 2021611111
Apr 202167145
May 20214566
Jun 20215574
Jul 202156710
Aug 202120116
Sep 20213244
Oct 20214377
Nov 202137237
Dec 202164214
Jan 202226923
Feb 2022513022
Mar 202262107
Apr 202223412
May 20222313

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 339 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 339, Issue 2
1 Nov 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNeuropharmacology

CTEP: A Novel Potent mGlu5 Inhibitor

Lothar Lindemann, Georg Jaeschke, Aubin Michalon, Eric Vieira, Michael Honer, Will Spooren, Richard Porter, Thomas Hartung, Sabine Kolczewski, Bernd Büttelmann, Christophe Flament, Catherine Diener, Christophe Fischer, Silvia Gatti, Eric P. Prinssen, Neil Parrott, Gerhard Hoffmann and Joseph G. Wettstein
Journal of Pharmacology and Experimental Therapeutics November 1, 2011, 339 (2) 474-486; DOI: https://doi.org/10.1124/jpet.111.185660

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleNeuropharmacology

CTEP: A Novel Potent mGlu5 Inhibitor

Lothar Lindemann, Georg Jaeschke, Aubin Michalon, Eric Vieira, Michael Honer, Will Spooren, Richard Porter, Thomas Hartung, Sabine Kolczewski, Bernd Büttelmann, Christophe Flament, Catherine Diener, Christophe Fischer, Silvia Gatti, Eric P. Prinssen, Neil Parrott, Gerhard Hoffmann and Joseph G. Wettstein
Journal of Pharmacology and Experimental Therapeutics November 1, 2011, 339 (2) 474-486; DOI: https://doi.org/10.1124/jpet.111.185660
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antipsychotic-VMAT2 Inhibitor Synergy: Schizophrenia Models
  • Rescue Pharmacology on Disease-Related GRIN Variants
  • Obesity thwarts preconditioning in TBI
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics